Stay updated on Emapalumab & Anakinra for COVID-19 Hyperinflammation Clinical Trial
Sign up to get notified when there's something new on the Emapalumab & Anakinra for COVID-19 Hyperinflammation Clinical Trial page.

Latest updates to the Emapalumab & Anakinra for COVID-19 Hyperinflammation Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange Detected- Updated site revision from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check14 days agoChange DetectedPadua, Italy was replaced by Padova, Italy in the locations list. This updates the site entry to the native Italian name for accuracy.SummaryDifference0.1%

- Check36 days agoChange DetectedAdded revision label v3.5.0 and removed revision label v3.4.3 from the page.SummaryDifference0.0%

- Check43 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision: v3.4.2 is now displayed, and the previous maintenance notice (Revision: v3.4.1) was removed.SummaryDifference0.4%

- Check79 days agoChange DetectedA site-wide notice about a lapse in government funding was added, and the page now shows Revision: v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

Stay in the know with updates to Emapalumab & Anakinra for COVID-19 Hyperinflammation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Emapalumab & Anakinra for COVID-19 Hyperinflammation Clinical Trial page.